ROSSARI — Rossari Biotech Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹28.06bn
- IN₹31.09bn
- IN₹23.96bn
Annual cashflow statement for Rossari Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | R2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1,363 | 1,442 | 1,776 | 1,852 | 2,025 |
| Depreciation | |||||
| Non-Cash Items | 81.4 | 200 | 160 | 174 | 60.4 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1,631 | -756 | -2,107 | -1,322 | -2,226 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 294 | 1,516 | 433 | 1,374 | 651 |
| Capital Expenditures | -382 | -329 | -1,313 | -1,585 | -2,647 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -2,607 | -1,480 | 281 | -252 | 452 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -2,989 | -1,809 | -1,032 | -1,837 | -2,195 |
| Financing Cash Flow Items | -21.5 | -61 | -160 | -165 | -252 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2,918 | 609 | 162 | 649 | 1,863 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 223 | 317 | -440 | 190 | 311 |